Detalhe da pesquisa
1.
GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med
; 387(13): 1196-1206, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170501
2.
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
Blood Adv
; 8(1): 236-247, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772981
3.
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
Blood Adv
; 8(7): 1600-1611, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878808
4.
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Blood Cancer J
; 14(1): 84, 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802346
5.
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
Clin Cancer Res
; 28(23): 5149-5155, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170461
6.
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 19(6): 356-364.e3, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029646
7.
Nutrition perceptions, needs and practices among patients with plasma cell disorders.
Blood Cancer J
; 12(4): 70, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443718
8.
Pancreatic cancer cachexia: a review of mechanisms and therapeutics.
Front Physiol
; 5: 88, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24624094